A Study of JR-141 in Patients With Mucopolysaccharidosis II

NCT03568175 · clinicaltrials.gov ↗
PHASE2,PHASE3
Phase
COMPLETED
Status
28
Enrollment
INDUSTRY
Sponsor class

Conditions

Interventions

Sponsor

JCR Pharmaceuticals Co., Ltd.